Quantitation of cytokine mRNA levels utilizing the reverse transcriptase-polymerase chain reaction following primary antigen-specific sensitization in vivo—I. Verification of linearity, reproducibility and specificity
- 31 May 1991
- journal article
- Published by Elsevier in Molecular Immunology
- Vol. 28 (4-5), 437-447
- https://doi.org/10.1016/0161-5890(91)90157-f
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis.The Journal of Experimental Medicine, 1989
- Tumor necrosis factor identified in multiple sclerosis brain.The Journal of Experimental Medicine, 1989
- Antibody, Macrophages, Dengue Virus Infection, Shock, and Hemorrhage: A Pathogenetic CascadeClinical Infectious Diseases, 1989
- Wound Macrophages Express TGF-α and Other Growth Factors in Vivo: Analysis by mRNA PhenotypingScience, 1988
- Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor.The Journal of Experimental Medicine, 1988
- Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemiaNature, 1987
- Shock and Tissue Injury Induced by Recombinant Human CachectinScience, 1986
- Identity of tumour necrosis factor and the macrophage-secreted factor cachectinNature, 1985
- Dihydrofolate reductase gene expression in cultured mouse cells is regulated by transcript stabilization in the nucleus.The Journal of cell biology, 1984
- The effect of polyoma virus, serum factors, and dibutyryl cyclic AMP on dihydrofolate reductase synthesis, and the entry of quiescent cells into S phaseJournal of Cellular Physiology, 1981